ea0011p538 | Endocrine tumours and neoplasia | ECE2006
Thomas D
, Kostoglou-Athanassiou I
, Bournazos S
, Mytakidis N
, Liakos V
, Vassiliou E
, Athanassiou P
, Kaldrymidis Ph
Adrenal carcinoma is a rare neoplasm with poor prognosis. Mitotane (o,p′-DDD) is the only known therapeutic agent with action on the adrenal. Although it has been used for many decades, its pharmacological properties and exact mechanism of action are still debated. It has been suggested that its therapeutic effect is dose-dependent (Baudin et al 2001). High performance liquid chromatography (HPLC) has been used for the exact measurement of mitotane dose.<p cla...